<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(3)</volume><submitter>Parks A</submitter><journal>Alzheimer's &amp; dementia (New York, N. Y.)</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12378430</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Characterizing clinician communication with patients about lecanemab: A qualitative study of clinicians across seven academic medical centers</pubmed_title><pmcid>PMC12378430</pmcid><pubmed_authors>Gomez L</pubmed_authors><pubmed_authors>Johnson K</pubmed_authors><pubmed_authors>Ritchie C</pubmed_authors><pubmed_authors>Dohan D</pubmed_authors><pubmed_authors>Shah S</pubmed_authors><pubmed_authors>Gale S</pubmed_authors><pubmed_authors>Paladino J</pubmed_authors><pubmed_authors>Parks A</pubmed_authors><pubmed_authors>Thacker A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterizing clinician communication with patients about lecanemab: A qualitative study of clinicians across seven academic medical centers</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-05-10T04:18:49.398Z</modification><creation>2026-04-08T01:28:56.332Z</creation></dates><accession>S-EPMC12378430</accession><cross_references/></HashMap>